Pfizer Will File For Full FDA Approval By End Of May, Expects $26 Billion In Vaccine Revenue
Updated May 4, 2021, 09:51am EDT Topline Pfizer and BioNTech, the manufacturers of one of the three authorized Covid-19 vaccines in the U.S., plan to file for full approval from the Food and Drug Administration by the end of May as they expect the vaccine to generate about $26 billion in revenue this year. Key…
Bitcoin 
Ethereum 
Tether 
BNB 
Solana 
USDC 
XRP 
Lido Staked Ether 
Dogecoin 
TRON